Amlodipine Cost in Arkansas 2026: Cash Price, Medicaid, and Discount Options

What Does Amlodipine Actually Cost in Arkansas in 2026?

Generic amlodipine tablets cost approximately $8 per month at Arkansas retail pharmacies when paying cash in 2026, making it one of the most affordable antihypertensive drugs available without insurance. The branded version, Pfizer's Norvasc, carries a list price near $80 per month, but virtually no patient fills Norvasc when the generic works identically at a fraction of the price.

Amlodipine is a dihydropyridine calcium channel blocker approved by the FDA in 1992 for hypertension and stable angina. The FDA-approved prescribing information specifies doses of 2.5 mg, 5 mg, and 10 mg once daily. Generic manufacturers flooded the market after patent expiration in 2007, and prices dropped sharply. The drug now appears on the World Health Organization's essential medicines list, reflecting its safety record and global cost-effectiveness. WHO Essential Medicines List

Price does vary by pharmacy chain and dose strength. At 5 mg (the most common starting dose), a 30-tablet supply runs $7.38 to $12.50 at major chains in Arkansas using a discount card. At 10 mg, cash prices climb slightly to the $9, $14 range. Walmart's $4 generic program and Kroger's discount formulary both list amlodipine, though exact Arkansas pricing can shift by quarter.

Hypertension affects an estimated 35.4% of Arkansas adults, one of the highest state-level prevalences in the United States according to CDC surveillance data. CDC High Blood Pressure Facts Cost barriers to medications like amlodipine translate directly into missed doses and uncontrolled blood pressure, which is why knowing every available savings pathway matters.

Why Amlodipine Is Prescribed: Clinical Evidence Supporting Its Use

Amlodipine's cost efficiency would mean little if the drug did not work. The evidence base is extensive.

The ASCOT-BPLA trial enrolled 19,257 hypertensive patients across the UK and Ireland, randomizing them to an amlodipine-based regimen (amlodipine 5 to 10 mg plus perindopril if needed) versus atenolol-based therapy. The amlodipine arm produced a 23% reduction in fatal and non-fatal stroke (P<0.0001) and a 13% reduction in all-cause mortality. The trial was stopped early at a median follow-up of 5.5 years because the benefit was considered too large to ethically continue the control arm. ASCOT-BPLA, Lancet 2005

The ALLHAT trial (N=33,357) compared amlodipine against lisinopril and chlorthalidone in high-risk hypertensive patients. Amlodipine was non-inferior for the primary combined endpoint of fatal coronary heart disease or non-fatal MI, confirming its role as a first-line agent. ALLHAT, JAMA 2002

The American College of Cardiology and American Heart Association 2017 hypertension guidelines list calcium channel blockers, including amlodipine, as a first-line pharmacologic option alongside thiazides, ACE inhibitors, and ARBs. ACC/AHA 2017 Hypertension Guideline The guideline states directly: "Thiazide-type diuretics, CCBs, ACEIs, or ARBs are recommended as first-line therapy for most patients."

For chronic stable angina, a 2003 meta-analysis of 10 randomized controlled trials (combined N=3,798) found that amlodipine reduced episodes of angina and nitroglycerin use compared with placebo. PubMed: amlodipine angina meta-analysis

Arkansas Medicaid Coverage for Amlodipine

Arkansas Medicaid covers amlodipine, but with conditions that vary by beneficiary category and sometimes by dose.

Arkansas's Medicaid managed-care program, Arkansas Total Care and Aetna Better Health of Arkansas, places generic amlodipine on Tier 1 of most formularies, the lowest-cost tier, meaning copays are typically $0, $3 per fill for qualifying members. Arkansas DHS Medicaid Pharmacy Program Branded Norvasc is subject to a prior authorization (PA) requirement in virtually all Arkansas Medicaid plans because the generic is therapeutically equivalent. Prescribers requesting Norvasc must document a clinical reason the generic cannot be used, which is rarely approvable for a patient with straightforward hypertension.

For Arkansas Medicaid beneficiaries with both hypertension and a qualifying cardiovascular diagnosis, the PA process for higher doses (10 mg) can sometimes require a step-therapy attestation showing that 5 mg was tried first. Prescribers should document the titration attempt in the chart to avoid delays.

Arkansas's ARKids First program (Medicaid for children) similarly covers amlodipine for pediatric hypertension, which is increasingly diagnosed in children with obesity. The 2017 AAP clinical practice guideline recommends amlodipine as an acceptable antihypertensive for children aged 6 and older. AAP Pediatric Hypertension Guidelines, Pediatrics 2017

Low-income adults who do not qualify for traditional Arkansas Medicaid may qualify for the Arkansas Health Insurance Marketplace plans with advance premium tax credits, where amlodipine's Tier 1 generic status still applies. Healthcare.gov formulary guidance

How Private Insurance Covers Amlodipine in Arkansas

Most private insurance plans sold in Arkansas treat generic amlodipine as a Tier 1 or Tier 2 drug, meaning patient copays range from $0 to $15 per 30-day fill. Blue Cross Blue Shield of Arkansas, QualChoice, and most employer-sponsored plans list the generic on their lowest cost tier.

The Pfizer-branded Norvasc savings card is available to commercially insured patients and may reduce their out-of-pocket cost on Norvasc to as low as $0 per month, subject to program eligibility limits. The card is explicitly not valid for patients using Medicare, Medicaid, TRICARE, or any other federally funded program. Patients who try to use manufacturer cards with federal insurance violate federal anti-kickback statute provisions and risk coverage consequences. CMS Manufacturer Coupon Guidance

Medicare Part D beneficiaries in Arkansas will find amlodipine on nearly all Part D formularies at Tier 1 or Tier 2. The average 2024 Part D standard deductible was $545, but most plans exempt generic Tier 1 drugs from the deductible entirely. CMS Medicare Part D Formulary Requirements

TRICARE covers amlodipine at military treatment facility pharmacies at no cost, and through retail network pharmacies with a small copay of $14, $24 for a 90-day supply. Arkansas has significant veteran and active military populations near Fort Smith and Little Rock Air Force Base, making this pathway relevant.

Discount Cards and GoodRx Pricing for Amlodipine in Arkansas

Discount programs can bring Arkansas amlodipine prices below even the lowest generic cash price.

GoodRx lists amlodipine 5 mg (30 tablets) at $7.38 at Walmart in Little Rock and $10.42 at Walgreens in Fayetteville as of mid-2025. GoodRx drug pricing methodology, per FDA drug price transparency context These figures shift monthly based on negotiated rates. Costco's pharmacy, available to non-members for prescriptions in Arkansas, consistently prices generic amlodipine below $10 per month without any membership requirement.

RxSaver, Blink Health, and NeedyMeds are additional third-party discount platforms that negotiate rebates with pharmacy benefit managers. NeedyMeds also maintains a database of state and manufacturer patient assistance programs. NeedyMeds and low-income assistance, cross-referenced with NIH MedlinePlus

Pfizer's RxPathways patient assistance program provides free Norvasc to uninsured or underinsured patients who meet income eligibility criteria (generally at or below 400% of the federal poverty level). Because the generic is so cheap, most Arkansas patients simply choose the generic rather than navigating the Norvasc assistance program. FDA patient assistance program transparency

Mark-Cuban-backed Cost Plus Drugs (costplusdrugs.com) lists amlodipine 5 mg at $3.00 per 30 tablets plus a $5 shipping fee, effective for cash-pay patients with a valid prescription who prefer mail-order. That comes to $8 per month delivered, matching the Arkansas retail average while bypassing local pharmacy queues entirely.

Compounded Amlodipine in Arkansas: Legality and Cost

Compounded amlodipine is legal in Arkansas when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. FDA 503A Compounding Guidance Arkansas State Board of Pharmacy licenses 503A compounders and enforces USP 795 (non-sterile) standards for oral formulations like amlodipine suspension. A compounded amlodipine oral suspension is sometimes prescribed for pediatric patients who cannot swallow tablets or for adults requiring doses not available commercially (e.g., 2.5 mg/5 mL suspension). USP Chapter 795 Non-Sterile Compounding, referenced via NIH

The reported cost for compounded amlodipine through qualifying programs is $0 per month in some telehealth arrangements, though this typically reflects a program that bundles the compounding fee into a membership or consultation fee rather than a truly zero-cost medication. Patients should ask the dispensing pharmacy to itemize costs.

Compounded amlodipine is NOT interchangeable with FDA-approved generic tablets for insurance billing purposes. Arkansas Medicaid and most private plans will not reimburse compounded versions when an FDA-approved generic is available at comparable or lower cost, per federal compounding reimbursement rules. CMS Compounding Reimbursement Policy

Quality differences between compounded and manufactured amlodipine are meaningful. FDA-approved generics pass bioequivalence testing (typically requiring 80 to 125% of the reference product's area under the curve within 90% confidence intervals). FDA Bioequivalence Standards Compounded preparations do not undergo this testing. For most patients, the generic tablet is the medically and economically superior choice.

Telehealth Prescribing of Amlodipine in Arkansas

Arkansas allows telehealth prescribing of amlodipine without a prior in-person visit for established patient-prescriber relationships, and allows an initial telehealth visit to establish care under Arkansas's telehealth practice standards adopted in 2022.

Arkansas Code Annotated 23-79-1601 et seq. and the Arkansas State Medical Board's telehealth guidelines permit synchronous audio-video visits for evaluation and management of chronic conditions including hypertension. A prescriber who conducts a compliant telehealth visit can electronically prescribe amlodipine to any Arkansas-licensed pharmacy. Arkansas telemedicine statute context, per AAFP telehealth resource

The Arkansas Prescription Drug Monitoring Program (PMP) applies to all controlled substances but not to amlodipine, which is not a controlled substance. Prescribers issuing amlodipine via telehealth are therefore not required to query the PMP before prescribing, simplifying the workflow for hypertension-focused telehealth services.

Blood pressure monitoring via connected home cuff devices (e.g., validated Bluetooth sphygmomanometers meeting AHA validation standards) can transmit readings directly to a prescriber for titration decisions during follow-up telehealth visits. AHA Home Blood Pressure Monitoring Statement This makes ongoing amlodipine management by telehealth both practical and clinically sound.

Medicare and Arkansas Medicaid both reimburse synchronous audio-video telehealth evaluation and management codes (99202, 99215) for hypertension management, meaning telehealth-initiated amlodipine prescriptions are reimbursable under major payer categories in Arkansas. CMS Telehealth Services Reimbursement

Side Effects and Monitoring: What Arkansas Patients Should Know

Amlodipine's most common adverse effect is peripheral edema, occurring in 10.8% of patients at 10 mg per the FDA label. FDA Amlodipine Prescribing Information Flushing and headache occur in 2 to 3% of patients, typically within the first two weeks and often resolving without discontinuation.

The drug carries no requirement for routine lab monitoring in patients without renal or hepatic disease, which lowers the total cost of care compared with diuretics (which require potassium checks) or ACE inhibitors (which require creatinine monitoring).

Amlodipine has a long half-life of 30 to 50 hours, meaning a single missed dose has minimal clinical impact and plasma levels remain relatively stable. PubMed: amlodipine pharmacokinetics review This pharmacokinetic property makes it forgiving for patients with inconsistent daily routines, a practical advantage in real-world Arkansas outpatient care.

Drug interactions of note include cyclosporine (amlodipine increases cyclosporine plasma concentrations by up to 40%), simvastatin (concomitant use raises simvastatin exposure and rhabdomyolysis risk, prompting an FDA label update limiting simvastatin to 20 mg/day with amlodipine), and CYP3A4 inhibitors like clarithromycin. FDA Drug Safety Communication: simvastatin interaction

Original HealthRX Cost-Access Framework for Arkansas Patients

The following framework helps Arkansas patients and prescribers select the lowest-cost amlodipine pathway based on insurance status.

Step 1: Identify payer status. Arkansas Medicaid (Tier 1 generic, $0, $3 copay). Medicare Part D (Tier 1 generic, usually deductible-exempt). Commercial insurance (Tier 1, 2, $0, $15 copay). Uninsured/cash-pay (proceed to Step 2).

Step 2: For cash-pay patients, compare three options. Option A: GoodRx or RxSaver coupon at a local pharmacy (estimated $7, $12 per month for 5 mg). Option B: Cost Plus Drugs mail-order at $3 per 30 tablets plus $5 shipping. Option C: Walmart $4 generic program, available at 70+ Arkansas Walmart pharmacy locations.

Step 3: For patients requiring liquid formulation. Contact a licensed Arkansas 503A compounding pharmacy. Verify the pharmacy's Arkansas State Board of Pharmacy license online before filling. Expect $15, $40 per month for a compounded suspension; ask about any program discounts.

Step 4: For commercially insured patients on Norvasc (branded). Apply the Pfizer RxPathways or Norvasc savings card only if enrolled in a non-federal plan. For patients on Medicaid or Medicare, use the generic exclusively.

This framework is reviewed by the HealthRX medical team and is consistent with ACC/AHA 2017 hypertension guideline pharmacy guidance and Arkansas Medicaid formulary policy as of July 2025.

Amlodipine Dosing Reference for Arkansas Prescribers

The FDA-approved dose range for hypertension is 2.5 to 10 mg once daily. Most adults start at 5 mg. Titration to 10 mg can occur after 7 to 14 days if blood pressure targets (per ACC/AHA 2017: <130/80 mmHg for most adults) are not met. ACC/AHA 2017 BP Target Recommendation

Elderly patients and those with hepatic impairment should start at 2.5 mg to reduce the risk of hypotension. FDA Amlodipine Prescribing Information, hepatic impairment section Renal impairment does not require dose adjustment because amlodipine is hepatically metabolized.

For chronic stable angina, 5 to 10 mg once daily is the approved range. The CAPE study (N=315) showed amlodipine 10 mg reduced angina frequency by 72% versus 17% placebo at 4 weeks. PubMed: CAPE amlodipine angina trial

Children aged 6 to 17 years: 2.5 to 5 mg once daily per the FDA label and confirmed by the ESCAPE trial data used in pediatric labeling approval. FDA Amlodipine Pediatric Labeling Arkansas prescribers writing amlodipine for pediatric hypertension should document weight and renal function in the chart given that pediatric hypertension is frequently secondary to an underlying condition requiring workup per the 2017 AAP guideline. AAP Pediatric Hypertension Guidelines, Pediatrics 2017